NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Surgical Safety Technologies (SST), the pioneer and leading provider of ambient technology healthcare…
NEW YORK and PARIS, Jan. 28, 2025 /PRNewswire/ -- Inato, the leading platform for clinical trial access and inclusivity, today…
Special issue "Advances in Metabolomics for Precision Medicine: From Biomarker Discovery to Clinical Applications" focuses on the latest challenges and…
Advances radiopharmaceutical leadership with addition of scalable manufacturing infrastructure and end-to-end clinical development capabilities Adds OCTEVY™, a registrational-stage diagnostic asset,…
CARY, N.C., Jan. 28, 2025 /PRNewswire/ -- InstantGMP™, a leader in fully integrated GMP-compliant software solutions for pharmaceutical manufacturing, proudly…
Advancement of next-generation APJ agonists with discontinuation of azelaprag Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial…
Dual-Targeted CD19/CD70 Allogeneic CAR T: Best-in-Class Design to Enhance Therapeutic Benefit and Expand Treatment Potential Across a Range of Autoimmune…
New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating inhibition of tumor growth in a…
Following a constructive Nasdaq hearing panel on January 7, 2025, Evaxion has been granted a 180-day extension in relation to…
Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with…